Inhibitor Therapeutics (INTI) Non-Current Assets (2015 - 2026)
Inhibitor Therapeutics (INTI) recorded Non-Current Assets of $50,384 in Q2 2026, down 35.2% from $77,734 a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Non-Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics reported Non-Current Assets of $64,307.
- Annual Non-Current Assets has a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q3 2021.
- Per Business Quant, the preceding three quarters came in at $57,410 (Q1 2026), $64,307 (Q4 2025) and $71,081 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 50,384.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,384.00 |
| Mar 31, 2026 | 57,410.00 |
| Dec 31, 2025 | 64,307.00 |
| Sep 30, 2025 | 71,081.00 |
| Jun 30, 2025 | 77,734.00 |
| Mar 31, 2025 | 84,268.00 |
| Sep 30, 2021 | 2,439.00 |
| Jun 30, 2021 | 9,762.00 |
| Mar 31, 2021 | 17,085.00 |
| Dec 31, 2020 | 24,408.00 |
| Sep 30, 2020 | 31,731.00 |
| Jun 30, 2020 | 39,054.00 |
| Mar 31, 2020 | 46,377.00 |
| Dec 31, 2019 | 53,700.00 |
| Sep 30, 2019 | 61,023.00 |
| Jun 30, 2019 | 68,346.00 |
| Mar 31, 2019 | 75,669.00 |
| Dec 31, 2018 | 82,992.00 |
| Sep 30, 2018 | 90,315.00 |
| Jun 30, 2018 | 97,638.00 |
API Access
Inhibitor Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();